Browse by Poster Presenter

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

H
Haas, Joanna

Haas and Partners LLC
(180) Utilizing Real World Data from a National Database of Living Donor Kidney Transplants to identify Targeted Subgroups for Planned Intervention Trials to prolong graft survival
Joanna Haas
Favorite
HADA, MANILA

AstraZeneca, Gaithersburg, US
(262) The diagnostic landscape of HRD testing based on cross-sectional survey of physicians and molecular biologists conducting testing (INDICATOR ONE)
MANILA HADA
Favorite
Hagberg, Katrina

Boston Collaborative Drug Surveillance Program
(150) To Link or Not to Link: Insights from comparison of CPRD Aurum and CPRD GOLD with linked Hospital Episode Statistics (HES) APC, HES Outpatient, and Cancer Registry data
Katrina Hagberg
Favorite
Haidar, Lara

University of Manitoba
(213) Marijuana Use and the Risk of Incident Venous Thromboembolism in People with HIV
Lara Haidar
Favorite
(222) Weight Loss Associated with Semaglutide Treatment in People with HIV
Lara Haidar
Favorite
Hakkarainen, Katja M

Parexel / Epidemiology & Real-World Science
(227) Systematic review of externally controlled (EC) trials, data used in them, and their role in regulatory decision-making
Katja M Hakkarainen
Favorite
Halasa, Tariq

Novo Nordisk A/S
(106) Safety and Effectiveness of Insulin Aspart versus Other Bolus Insulins in Women with Pre-existing Type 1 Diabetes During Pregnancy
Tariq Halasa
Favorite
Hallgreen, Christine

Copenhagen Centre for Regulatory Science, University of Copenhagen
(004) Mapping the Information Pathways of Adverse Reactions Through Clinical Event Sequences, Patient Interactions with the Healthcare System and Generation of Different Data Streams – a Qualitative Pilot Study
Christine Hallgreen
Favorite
(029) Trajectories of EU Paediatric Investigation Plans for Oncology approved since 2007 and Resulting Paediatric Cancer Indications
Christine Hallgreen
Favorite
Hammill, Bradley

Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
(232) Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population
Bradley Hammill
Favorite
Hampp, Christian

Regeneron Pharmaceuticals, Inc., Tarrytown, NY
(240) Bridging clinical trial life expectancy (LE) inclusion criterion in the real-world (RW) setting: targeted literature review results for modeling feasibility in relapsed and refractory multiple myeloma (RRMM) patients
Christian Hampp
Favorite
Harada, Sayoko

Pharmaceuticals and Medical Devices Agency
(129) Characteristics of data collected in MID-NET®
Sayoko Harada
Favorite
Harikumar, Bhavna

Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education
(037) Clinical Characteristics of Patients Prescribed with Dapagliflozin in a Tertiary Care Teaching Hospital in India
Bhavna Harikumar
Favorite
Harrak, Hind

Regeneron Pharmaceuticals, Inc.
(171) Clinical Outcomes and Population Characteristics in Fibrodysplasia Ossificans Progressiva: A Systematic Literature Review
Hind Harrak
Favorite
Hasegawa, Tomoaki

Pharmaceuticals and Medical Devices Agency
(217) Risk Assessment of Hypocalcaemia in Patients with Renal Impairment Prescribed Bisphosphonate Preparations Using the MID-NET® in Japan
Tomoaki Hasegawa
Favorite
Hauben, Manfred

Pfizer Inc
(079) Graph Machine Learning in Adverse Events Safety Signal Management: A Research Proposal
Manfred Hauben
Favorite
Havard, Alys

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
(149) First trimester exposure to smoking cessation pharmacotherapies and the risk of major congenital malformations: A multi-national cohort study
Alys Havard
Favorite
Haviland, Miriam

IQVIA
(190) Representativeness of race and ethnicity in Real World Data: a comparison by disease type
Miriam Haviland
Favorite
(261) Low Antibody Titers Demonstrate Significantly Increased Risk of SARS-CoV-2 Infection in a Highly Vaccinated Population from the National Basketball Association
Miriam Haviland
Favorite
Hayes, Kaleen

Brown University School of Public Health, Providence, Rhode Island, USA
(113) Trends in osteoporosis drug initiation and use among community dwelling older adults
Kaleen Hayes
Favorite
Haynes, Kevin

Janssen Pharmaceuticals
(070) Medical chart review of selected adverse event of special interest (AESI) to support rapid safety assessment of the Janssen COVID-19 vaccine (JCOVDEN): a validation study using US electronic health records and claims data
Kevin Haynes
Favorite
(301) Methodological development of an enhanced safety surveillance for the Janssen COVID-19 vaccine (JCOVDEN) through rapid cycle analysis of US administrative claims data
Kevin Haynes
Favorite
Heck, Julia

University of North Texas
(120) Maternal acetaminophen intake in pregnancy and the risk of childhood cancer
Julia Heck
Favorite
Heller, Carrie

Sanofi
(C05) Phased Target Trial Design and Meta-Analysis in a Head-to-Head Treatment Comparison
Carrie Heller
Favorite
Hernandez-Con, Pilar

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(188) Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: a cross-sectional study in the United States
Pilar Hernandez-Con
Favorite
(200) The Cascade of Care in Individuals Screened for Hepatitis C Virus Infection in Emergency Departments
Pilar Hernandez-Con
Favorite
Her, Qoua

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
(274) Adapting the prevalent new-user study design to evaluate the effects of drug discontinuation: A simulation study
Qoua Her
Favorite
Herzog, Mackenzie

IQVIA
(196) Epidemiology of Injuries among National Basketball Association Players: 2013-14 through 2018-19
Mackenzie Herzog
Favorite
Hester, Laura

Janssen R&D, LLC
(255) Evaluating bias from index date selection methods under varying assumptions in external control analyses using real-world comparators
Laura Hester
Favorite
Hodgkinson, Victoria

Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary
(081) Real-World Survival Effectiveness of Edaravone in Amyotrophic Lateral Sclerosis: A Propensity Score Weighted, Registry-based, Canada-wide Cohort Study
Victoria Hodgkinson
Favorite
Hoe, Jakob

Copenhagen Phase IV unit, (Phase4CPH), Department of Clinical Pharmacology, and Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
(100) Timing and Duration of Remdesivir Treatment Among Individuals Hospitalized due to COVID-19 in the Capital Region of Denmark
Jakob Hoe
Favorite
Hoffman, Sarah

Carelon Research
(138) Monitoring pregnancies exposed to galcanezumab for migraine in a United States (US) administrative claims database
Sarah Hoffman
Favorite
Hong, Bin

School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
(001) Association of ticagrelor versus clopidogrel with major adverse cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention across categories of liver disease
Bin Hong
Favorite
Hooda, Naushin

EpidStrategies
(244) Survey of Infection Control Practices at Ambulatory Surgery Centers (ASCs) and Outpatient Hospitals that Perform Gastrointestinal Endoscopic Procedures in the United States
Naushin Hooda
Favorite
Hoogendoorn, Wilhelmina

IQVIA
(231) Lessons learned for data harmonisation and integration from secondary use of randomised controlled trial (RCT) and real-world data in the context of a study to evaluate external comparator arm study results versus RCT results
Wilhelmina Hoogendoorn
Favorite
(258) Examining the External Comparator Arm Design: A Simulation Study
Wilhelmina Hoogendoorn
Favorite
Hoover, Chaundra

Cerner Enviza, an Oracle company
(265) Quality of Electronic Health Records: Variability of Missing Data for Social Determinants of Health by Healthcare Systems
Chaundra Hoover
Favorite
Horton, Daniel

Rutgers University
(273) Validation of ICD-9- and ICD-10-based Diagnostic Algorithms for Juvenile Idiopathic Arthritis within a Large U.S. Commercial Claims Database
Daniel Horton
Favorite
Horwitz, Henrik

Bispebjerg and Frederiksberg Hospital
(271) Interferon-beta exposure in-utero and the risk of infections
Henrik Horwitz
Favorite
Hoveling, Liza

PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands
(003) Survival and drug treatment patterns in multiple myeloma patients exposed to an anti-CD38 monoclonal antibody, a proteasome inhibitor and an immunomodulatory imide drugs
Liza Hoveling
Favorite
Howell, Ashley

Regeneron Pharmaceuticals, Inc.
(A33) A Retrospective Cohort Study Using Administrative Claims to Compare the Incidence of Eosinophilic Granulomatosis with Polyangiitis in Patients with and without Asthma, Stratified by Asthma Severity
Ashley Howell
Favorite
Hsu, Ling-Chen

Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
(291) The Real-Life Effectiveness of Antiviral Therapy in Hepatocellular Carcinoma Patients with Low HBV-DNA Levels After Hepatectomy: A Retrospective Cohort Study in Taiwan
Ling-Chen Hsu
Favorite
Htoo, Phyo Than

Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
(276) Addressing bias due to socioeconomic status in the comparative effectiveness of sodium-glucose co-transporter 2 inhibitors vs. sulfonylureas in patients with type 2 diabetes
Phyo Than Htoo
Favorite
(B47) Cardiovascular risk stratification in patients with type 2 diabetes
Phyo Than Htoo
Favorite
Huang, Hao-Hsin

Chang-Gung Memorial Hospital, Linkou
(010) Association between the Use of Glucagon-like Peptide 1 Agonist and the Risk of Psoriasis in Diabetes Patients Compare to Dipeptidyl Peptidase-4 inhibitors in Taiwan
Hao-Hsin Huang
Favorite
Huang, Hsin-Yi

School of Pharmacy, National Taiwan University, Taipei, Taiwan
(255) Risk of Severe Uterine Bleeding of Oral Anticoagulants use in Postmenopausal Women Aged 55 Years or Older: An Application of the U.S. Sentinel Routine Querying Tools to the Taiwan Sentinel Data Model
Hsin-Yi Huang
Favorite
Huang, Kui

Pfizer, Inc.
(A38) Epidemiology of rare kidney diseases in the United Kingdom using a large rare renal registry
Kui Huang
Favorite
Huang, Wenxi

University of Florida
(040) Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries with Heart Failure
Wenxi Huang
Favorite
(165) Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction between Asian and White Patients: A Meta-Analysis of Randomized Outcomes Trials
Wenxi Huang
Favorite
(A06) The Impact of Contextual-Level Social Determinants of Health on Heart Failure Readmission and Mortality in Patients Hospitalized for Heart Failure
Wenxi Huang
Favorite
Huang, Yuan-Yu

Institute of Clinical Pharmacy and Pharmaceutical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan
(020) Gender differences in anticancer drugs among patients with Non-Small Cell Lung Cancer in Taiwan
Yuan-Yu Huang
Favorite
Hua, Wei

Division of Epidemiology I, Office of Surveillance and Epidemiology, CDERR, FDA
(190) Quantitative Bias Analysis Methods for Summary Level Epidemiologic Data: A Systematic Review
Wei Hua
Favorite
Hughes, John E.

School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
(097) Adverse Drug Reactions in an Ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
John E. Hughes
Favorite
(109) Potentially inappropriate prescribing and its association with adverse drug reaction-related hospital admissions
John E. Hughes
Favorite
(115) Drug-Drug Interactions and Adverse Drug Reaction Hospital Admissions in the Older Population: A Prospective Cohort Study
John E. Hughes
Favorite
(145) The European Drug-Drug Interaction (EuroDDI) study protocol: a cross country comparison of the prevalence of drug-drug interactions in the older community-dwelling population
John E. Hughes
Favorite
HU, Lin

Department of Pharmacy Administration and Clinical Pharmacy, Peking University, China
(293) Association Between β-lactam Allergy Documentation and Outpatient Antibiotic Prescribing in Primary Healthcare Facilities in China
Lin HU
Favorite
Hurst, William

Sanofi R&D epidemiology & BR
(003) What are the main expectations of patients with hemophilia regarding treatment?
William Hurst
Favorite
HURTADO, ISABEL

FISABIO
(041) Factors associated with opioid overdose and dependence: retrospective cohort study with 959,286 patients initiating opioid therapy
ISABEL HURTADO
Favorite
(085) Long-term use of prescription opioids and mortality: a population based, propensity-weighted cohort study with 767,299 patients initiating therapy
ISABEL HURTADO
Favorite
Hussain, Salman

Masaryk University
(155) Cost-Effectiveness of Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma in Canada
Salman Hussain
Favorite